The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of paclitaxel and carboplatin plus PD-1 inhibitors combined with anlotinib as first-line treatment for advanced esophageal cancer.
 
Mingfang Xu
No Relationships to Disclose
 
Yu Pu
No Relationships to Disclose
 
Yuzhu Jiang
No Relationships to Disclose
 
Hong Liu
No Relationships to Disclose
 
Yan Feng
No Relationships to Disclose
 
Chengyuan Qian
No Relationships to Disclose
 
Nan Dai
No Relationships to Disclose
 
Dong Wang
No Relationships to Disclose
 
Mengxia Li
No Relationships to Disclose